{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T16:21:43Z","timestamp":1769358103631,"version":"3.49.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,7,9]],"date-time":"2004-07-09T00:00:00Z","timestamp":1089331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s00404-004-0643-9","type":"journal-article","created":{"date-parts":[[2004,7,8]],"date-time":"2004-07-08T11:51:38Z","timestamp":1089287498000},"page":"268-270","source":"Crossref","is-referenced-by-count":17,"title":["Erythema multiforme major following docetaxel"],"prefix":"10.1007","volume":"271","author":[{"given":"Christina","family":"Moisidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"M\ufffdbus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,7,9]]},"reference":[{"key":"CR1","unstructured":"Aventis Pharmaceuticals (2000) Taxotere prescribing information. Aventis Pharmaceuticals, Collegeville"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000018132","volume":"198","author":"Correia","year":"1999","unstructured":"Correia O, Azevedo C, Pinto Ferreira E, Braga Cruz F, Polonia J (1999) Nail changes secondary to docetaxel (taxotere). Dermatology 198:288?290","journal-title":"Dermatology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00000421-200212000-00015","volume":"25","author":"Eich","year":"2002","unstructured":"Eich D, Scharffetter-Kochanek K, Eich HT, Tantcheva-Poor I, Krieg T (2002) Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer. Am J Clin Oncol 25:599?602","journal-title":"Am J Clin Oncol"},{"key":"CR4","first-page":"197","volume":"19","author":"Hassett","year":"2001","unstructured":"Hassett G, Harnett P, Manolios N (2001) Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol 19:197?200","journal-title":"Clin Exp Rheumatol"},{"key":"CR5","first-page":"267","volume":"l2","author":"(2001)","year":"2001","unstructured":"Various (2001) Cutaneous drug reaction case reports from the world literature. Am J Clin Dermatol 12:267?274","journal-title":"Am J Clin Dermatol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-004-0643-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-004-0643-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-004-0643-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:44:41Z","timestamp":1559065481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-004-0643-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1007\/s00404-004-0643-9","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,9]]}}}